Chemistry discovery points to next generation inhibitors of PARP-1, a critical target in ovarian, breast and prostate cancers.
ONA Expresses Skepticism, Cautious Optimism Regarding OHSU-Legacy Merger – Oregon Business
Search OHSU News
Stories OHSU News
POR Blood, Toil, and Taxoteres: Biological Determinants of Treatment-Induced ctDNA Dynamics for Interpreting Tumor Response
Joe Rojas's Instagram, Twitter & Facebook on IDCrawl
OHSU researchers identify promising next-generation cancer treatment
Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery - ScienceDirect
MRI innovation for the first time reveals cells' energy activity in organs and tissues
Protein study could one day advance Parkinson's, breast cancer care